Research and development (includes $18,123and $9,685 of share-based compensation expense for the three months ended December 31, 2025 and 2024 and $40,218and $30,128 for the nine months ended December 31, 2025 and 2024, respectively)

Name: Roivant Sciences Research and development (includes $18,123and $9,685 of share-based compensation expense for the three months ended December 31, 2025 and 2024 and $40,218and $30,128 for the nine months ended December 31, 2025 and 2024, respectively) by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Roivant Sciences·Business Segments·1 segment·Rolls up to R&D

Breakdown

Segment	Q3 '25	Q4 '25	Q1 '26
Business Segments	$40.66M	$41.40M	$43.20M
Total	$164.57M	$165.38M	$198.95M

Segments

Business SegmentsView metric